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Abstract
The EC1 domain of E-cadherin has been shown to be important for cadherin-cadherin homophilic 
interactions. Cadherins are responsible for calcium-mediated cell-cell adhesion located at the 
adherens junction of the biological barriers (i.e., intestinal mucosa and the blood-brain barrier 
(BBB). Cadherin peptides can modulate cadherin interactions to improve drug delivery through 
the blood-brain barriers (BBB). However, the mechanism of modulating the E-cadherin 
interactions by cadherin peptides has not been fully elucidated. To provide a basis for subsequent 
examination of the structure and peptide-binding properties of the EC1 domain of human E-
cadherin using solution NMR spectroscopy, the 1H, 13C and 15N backbone resonance of the 
uniformly labeled-EC1 were assigned and the secondary structure was determined based on the 
chemical shift values. These resonance assignments are essential for assessing protein-ligand 
interactions and are reported here.
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Biological Context
E-cadherin has an important role in regulating calcium-dependent cell-cell adhesion at the 
adherens junctions of critical biological barriers such as the intestinal mucosa and blood-
brain barrier (BBB). Cell adhesion is mediated by homotypic interaction of E-cadherins. E-
cadherin has cytoplasmic, trans-membrane, and extracellular (EC) regions. The extracellular 
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region is composed of five repeat domains called EC1 to EC5 (Makagiansar et al. 2002; 
Zhang et al. 2009). The EC1 domain has a role in selective homotypic cadherin-cadherin 
interactions and it is also responsible for heterotypic interactions between E-cadherin and 
αEβ7 integrin to achieve cell-cell adhesion (Cepek et al. 1994; Trivedi et al. 2012; Shiraishi 
et al. 2005). E-cadherin peptides derived from the conserved sequence of EC1 have been 
applied to enhance the BBB permeation of 14C-mannitol and 3H-daunomycin through the 
paracellular pathways in in-situ rat brain perfusion model (Kiptoo et al. 2011). This result 
suggests that E-cadherin peptides modulate the cadherin-cadherin interactions in the 
adherens junctions of the BBB to increase the porosities of the paracellular pathways of the 
BBB. It is proposed that the activity of the cadherin peptide is due to competitive binding to 
the EC1 domain of E-cadherin.
The high-resolution structure of human E-cadherin has not been solved, but the solution 
structure of the EC1 domain of mouse E-cadherin has been previously determined using 
NMR and it has a similar fold with the immunoglobulin protein (Overduin et al. 1996). 
Human EC-1 is 84% identical to the mouse homologue. Here, the backbone resonance 
assignments of the EC1 domain of human E-cadherin were determined and the chemical 
shifts for HN, N, CA, CB and CO are reported. The chemical shift index (CSI) was also 
applied to predict the EC1 secondary structure.
Method and Experiments
Overexpression and purification of human EC1 domain
The cDNA corresponding to the 110 residues from human E-cadherin 1 domain (EC1) plus 
28 residues extending into EC2 to encode the calcium binding region was synthesized and 
subcloned into the pASK-IBA6 plasmid (BlueHeron) to generate a protein containing the 
first 138 residues of E-cadherin. pASK-IBA6 has 3681 bp DNA and carries AmpR, f1 origin 
and Multi Cloning Site 1 (MCS 1) gene regions (Genosys, Woodland, TX). 5′ Xba 1 and 3′ 
Xho 1 restriction sites were used to insert the gene. In total, the protein product consists of 
150 residues, including Streptag I (WSHPQFEK), Factor Xa and EC1 sequences. After the 
EC1 cDNA was successfully subcloned into the plasmid, it was transformed into the DH5α 
competent cells, spread on the LB agar plates containing 100 mg/L ampicillin, then 
incubated at 37°C overnight. The plasmid DNA was isolated and purified using Qiagen Spin 
Miniprep Kit (Stratagene). The DNA concentration was determined using UV absorbance 
on a Spectrometer Carry 300 at 260 nm (A260).
To obtain 15N-13C-labeled protein for 3D NMR analysis, EC1 was expressed in E.coli BL21 
(DE3) cells grown in M9 minimal media containing 15N-labeled ammonium chloride 
and 13C-labeled glucose. A 10 mL starter culture was grown for 16 hours. A 10 mL aliquot 
of the starter cell culture was added to each of 4×1 L culture flasks containing 250 mL of 
M9 minimal of cell culture. The cells were grown at 37°C to an OD600 of 0.5– 0.6; then 
anhydrotetracycline was added at a final concentration of 250 mL (Promega Inc., Madison, 
WI) to induce the expression of the EC1 protein. After 6 h of additional growth at 30° C, 
cells were harvested by centrifugation at 4500xg and cell pellets were stored at −80°C prior 
to use.
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Cell pellets containing the overexpressed EC1 were resuspended in 10 mL of 100 mM Tris-
HCl, 150 mM NaCl, 1 mM EDTA, 0.02% NaN3 at pH 8.0 (Buffer B) and lysed by three 
passes through a French Pressure cell at 20,000 psi. To remove cellular debris, the lysate 
was centrifuged at 21,000xg for 1 hour at 4 °C. The supernatant containing soluble EC1 was 
diluted with an equal volume of buffer B then concentrated via centrifugation at 4,500 rpm 
for 20 minutes, using a 10,000 kDa cut-off Amicon Ultra concentrator (Millipore, Billerica, 
MA). The resulting solution was loaded onto a Strep Tactin II affinity column with size 
5.0×0.6 cm (GE Healthcare Life Sciences, Pittsburgh, PA) attached to a peristaltic pump 
after equilibration with buffer B at room temperature. The column was then washed with 
buffer B at 2 mL/min before eluting EC1 with buffer E (buffer E contains 100 mM Tris-
HCl, 150 mM NaCl, 1 mM EDTA, 0.02% NaN3, 2.5 mM desthiobiotin and 1 mM 
diothiothreitol (DTT) at pH 8.0 with a flow of 2 mL/min. The protein fractions were pooled 
and concentrated to 1.5 mL. The purity of each EC1 fraction was determined by 4–12% 
Tris-Bis SDS-PAGE. The protein concentration was determined from UV absorbance at 280 
nm and calculated using the predicted molar absorption coefficient of 19,480 M−1 cm−1 
(Makagiansar et al. 2002). Because cell binding experiments confirm the N-terminal tag 
does not interfere with EC1 function (unpublished data), the tagged protein was studied. 
Final pure EC1 was stored in the buffer E at 4 °C.
In preparation for 3D NMR experiments, 600 μL of purified protein was dialyzed overnight 
against 1 L NMR buffer (20 mM Potassium Phosphate, 5 mM DTT, 50 mM KCl, 5 mM 
CaCl2, 50 μM Sodium Azide) at pH 6.8 and 4 °C in Slide-a-Lyzer dialysis cassette (5,000 
kDa cut-off, Thermo Scientific, PA) (Overduin et al. 1996).
NMR Spectroscopy
All triple resonance 3D 1H-15N-13C were performed on a 1 mM protein sample using a 
Bruker Avance 800 MHz NMR spectrometer equipped with a cryoprobe, and spectra were 
recorded on the uniformly 13C/15N-labeled sample in 95% H2O/5% D2O using the 
following pulse programs HNCACB (Wittekind and Mueller 1993), CBCA(CO)NH 
(Grzesiek and Bax 1992), HNCO (Ikura et al. 1990), HNCA (Ikura et al. 1990) and 
HNCOCA (Bax et al. 1991).
Data were processed using NMRpipe (Delaglio et al. 1995), and the NMR assignment 
program Sparky was used to determine position of peaks in the spectra acquired (Goddard 
TD, Kneller DG).
Assignments and data deposition
Approximately 90% of human EC1’s resonances were assigned using the standard 
sequential backbone assignment method. The data was submitted to the PINE server for 
semiautomated protein backbone assignment and rechecked for accuracy. The assignment 
data are deposited in BioMagResBank (http://www.bmrb.wisc.edu under accession number 
19443). Figure 1 depicts the 15N-HSQC of the EC1 domain. Most of the peaks in the 2D 
HSQC spectrum were assigned. Of the 138 residues in EC1, E64, L66, V81, I96, Q101, 
E111, M128, L122, A135 and D136 could not be assigned. The vast majority of the residues 
in the conserved region of EC1 domain were assigned; these sites are important for binding 
Prasasty et al. Page 3













to cadherin peptides. Residues 111–138 comprise the calcium-binding region adjacent to the 
core domain. Without this extension, EC1 was not sufficiently well behaved in solution to 
achieve a well-resolved HSQC. Five residues from this region could not be assigned. Six of 
12 residues within the tag sequence of EC1 were also assigned, including W(-11), S(-10), 
Q(-7), F(-6), G(-1), R(0). The tag sequence is needed to help EC1 purification using single 
step streptactin column chromatograpy and it does not interfere with EC1 function. 
Moreover, the N-terminal extension in EC1 prevented the native dimerization of EC1 
domain when it was produced in the host cell by fusing it from cytoplasm into periplasm 
space as a monomeric EC1 domain. Side chain amide NH2 groups were not assigned but are 
identified in Figure 1 with lines connecting the paired peaks. Three tryptophan residues are 
present in EC1, and the NH indole moieties from these residues are circled in Figure 1. A 
few peaks appear for which no assignment could be made, and these peaks are enclosed in 
black boxes.
Despite having optimized the construct and conditions for successfully accomplishing 
backbone assignment, experiments to identify side chain resonances beyond CB resulted in 
poor data and a limited number of additional side chain assignments. Based on these results, 
a high-resolution three-dimensional structure cannot be determined under these conditions. 
As such, chemical shift index (CSI) analysis was performed using the chemical shifts of HN, 
N, CA, CO, and CB atoms (Figure 2) to predict the protein’s secondary structure (Wishart 
and Sykes 1994; Wishart et al. 1992). The result shows that the majority of the secondary 
structure in EC1 is beta sheet with one alpha helix; this structural prediction is consistent the 
X-ray crystal structure and the NMR structure of the EC1 domain of mouse E-cadherin 
(Figure 3).
The backbone NMR assignments of EC1 were determined and used to elucidate the 
secondary structure of the protein. The study performed here is important because it serves 
as a baseline for assessing the function of human EC1. The data set provides the foundation 
for carrying out perturbation experiments, which enable examination of the binding 
properties of the EC1 domain of human E-cadherin with itself, E-cadherin-derived peptides 
and other binding partners that are responsible for regulating adherens junctions.
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Assigned 2D 15N-HSQC spectrum of 1.0 mM EC1 in 20 mM potassium phosphate, pH 6.8 
at 37°C, acquired on a Bruker Avance 800 MHz NMR spectrometer with a cryoprobe.
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The chemical shift index of individual nuclei and consensus plot were calculated from HA, 
CA, CO, and CB chemical shifts of the EC1 domain of human E-cadherin
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Amino acid sequence alignment between human EC1 and mouse EC1 used for NMR 
assignment, with beta sheet regions in the blue arrow boxes and alpha helix regions in the 
green cylinder boxes. The bold residues are the tag sequence in human EC1. The red color 
residues are indicating the polymorpishm between human EC1 and mouse EC1. The asterisk 
residues are the similar residues between human EC1 and mouse EC1. These secondary 
structure prediction data are derived from the chemical shift index of the solution 3D NMR 
experiments (Wishart and Sykes, 1994).
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